# Ciprofloxacin Hydrochloride

NDC: 69367-385
Generic name: Ciprofloxacin Hydrochloride
Labeler / Manufacturer: Westminster Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20240523

FDA application: ANDA076593

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69367-385"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69367-385
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c47250c2-bece-46b5-8b3b-b7c97d9005d8